Sudanese child with complex heart defect undergoes successful high-risk surgery

Ghaziabad: A four-year-old child from Sudan, born with a major congenital heart defect, successfully underwent a high-risk ...

CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies

Four autoimmune patients treated to date demonstrate deep B-cell depletion sustained for at least 28 days; initial efficacy ...
HDFN Companion

Early screening helps prevent severe jaundice caused by HDFN

Early transcutaneous bilirubin screening helps identify newborns at risk for dangerous jaundice related to HDFN before ...

Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration

Detailed price information for Fibrogen Inc CS (FGEN-Q) from The Globe and Mail including charting and trades.

Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rare diseases, today announced that the U.S. Food ...

Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation

Restructuring Supports RYTELO® U.S. Commercial Strategy and Investment in Clinical Development Expected to Reduce 2026 Projected Operating ...

Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS

Oral presentation from pooled analyses of the IMerge population suggests that treatment-emergent cytopenias may reflect on-target effects associated with meaningful clinical outcomes, including ...
The Punch on MSN

Inside Nigeria’s under ground blood market

Discover Nigeria's dangerous underground blood market, where poverty drives youths to sell unscreened blood, risking their ...
WSVN 7News

FLFR paramedics will be able to provide whole blood to trauma patients before reaching hospital under new partnership

In a significant breakthrough for Fort Lauderdale paramedics, city commissioners approved an advancement in emergency medical care that will allow<a class="excerpt-read-more" href=" More ...

FibroGen, Inc.: Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration

Company is on track to file the Phase 3 protocol in the fourth quarter of 2025 SAN FRANCISCO, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that the Office of Orphan ...
PharmiWeb

Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global ...

Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in ...
Houston Press

Abortion Ban is Pushing Medical Students Out of Texas

The patient pregnant with twins was having complications likely to lead to the death of both fetuses. As Dr. Isabel Bryan scrubbed in for her shift, she OB-GYN students are increasingly opting to do ...